≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Acute myringitis

DOID Endpoint Browser PheWeb

H8_MYRINGACU

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H73.0
  • Hospital discharge: ICD-9 — 3840
  • Cause of death: ICD-10 — H73.0
  • Cause of death: ICD-9 — 3840

2 out of 7 registries used, show all original rules.

255

4. Check minimum number of events

None

255

5. Include endpoints

None

255

6. Filter based on genotype QC (FinnGen only)

255

Control definitions (FinnGen only)

Control exclude
H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H73
Name in latin
Myringitis acuta

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3427 1705 1712
Only index persons 2624 1359 1265
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.05
Only index persons 0.05 0.05 0.05
Median age at first event (years)
Whole population 11.72 13.87 9.40
Only index persons 19.24 21.74 16.56

-FinnGen-

Key figures

All Female Male
Number of individuals 255 165 90
Unadjusted period prevalence (%) 0.05 0.06 0.04
Median age at first event (years) 40.44 37.30 46.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
230
Matched controls
2301
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H73.0
ICD-10 Finland
Acute myringitis
4853.5
284.3
216
7
H66.0
ICD-10 Finland
Acute suppurative otitis media
18.7
48.0
77
60
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
+∞
37.5
35
*
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
57.2
25.9
30
6
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
97.3
24.2
26
*
UDC00
NOMESCO Finland
Ear microscopy
9.6
23.1
49
63
H65.3
ICD-10 Finland
Chronic mucoid otitis media
242.1
22.0
22
*
H66.9
ICD-10 Finland
Otitis media, unspecified
8.3
18.4
42
60
H65.2
ICD-10 Finland
Chronic serous otitis media
+∞
16.9
16
*
3840A
ICD-9 Finland
Other disorders of tympanic membrane, Acute myringitis without mention of otitis media
+∞
14.7
14
*
H65.0
ICD-10 Finland
Acute serous otitis media
32.3
14.1
18
6
DCD00
NOMESCO Finland
Myringoplasty
+∞
13.7
13
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
12.6
12
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.6
11.4
142
872
DC1AD
NOMESCO Finland
Temporalbone CT
34.3
10.4
13
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.6
9.5
82
398
4122
FHL
Tympanostomy (tympanic tube)
104.1
9.5
10
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
5.2
9.4
29
62
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
+∞
9.4
9
*
H73.1
ICD-10 Finland
Chronic myringitis
+∞
9.4
9
*
H71
ICD-10 Finland
Cholesteatoma of middle ear
+∞
8.4
8
*
DFF00
NOMESCO Finland
Pure tone audiometry
4.3
8.4
31
81
S02CA02
ATC
flumetasone and antiinfectives; otic
5.7
8.3
23
44
H92.0
ICD-10 Finland
Otalgia
5.1
8.1
25
54
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
46.6
7.8
9
*
H01
ICPC
Ear pain/earache
3.2
7.6
42
152
J01CA04
ATC
amoxicillin; systemic
2.8
7.3
202
1655
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
7.2
47
188
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
6.9
45
180
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
17.3
6.8
10
6
M54.4
ICD-10 Finland
Lumbago with sciatica
2.9
6.7
42
165
H60.3
ICD-10 Finland
Other infective otitis externa
10.5
6.6
12
12
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
+∞
6.3
6
*
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
27.5
6.3
8
*
TDA90
NOMESCO Finland
Removal wax from ear
13.0
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
63
220
3.48
14.97
2.2
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
53
261
2.30
6.22
2.4
1.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
75
480
1.80
4.13
4.2
3.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
23
4.48
4.12
14.8
7.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
50
285
1.94
3.94
2.2
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
114
834
1.66
3.83
6.8
6.8
mmol/l
1.2
1.2
0.94
104
761
(36304419) Bacteria [Presence] in Urine
79
533
1.70
3.56
3.9
2.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
146
1159
1.61
3.39
5.2
5.0
mmol/l
6.5
6.6
0.11
137
1052
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
85
596
1.64
3.27
3.3
2.4
u/l
63.5
56.2
0.23
75
553
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
94
676
1.62
3.27
3.9
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
96
694
1.61
3.26
2.1
1.8
pmol/l
99.7
95.1
0.56
61
362
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
124
956
1.58
3.20
5.0
4.0
—
—
—
0
0
(3026782) Osmolality of Urine
57
367
1.71
3.00
3.1
2.6
mosm/kgh2o
560.6
550.9
0.11
47
318
(3030467) Casts [#/volume] in Urine by Automated count
76
529
1.62
2.97
4.1
3.0
e6/l
0.4
0.4
0.02
55
393
(3000850) Epithelial cells [#/volume] in Urine
60
393
1.69
2.97
2.8
2.5
e6/l
7.9
6.8
0.14
51
350
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
17
4.82
2.94
1.4
1.7
%
13.0
13.2
—
8
17
(42870588) Differential panel, method unspecified - Blood
94
695
1.56
2.83
8.5
6.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
132
2.08
2.82
1.7
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
12
42
2.95
2.79
4.1
7.6
mmol/l
1.3
1.2
0.08
12
36
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
42
2.95
2.79
1.2
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
81
585
1.56
2.68
4.0
3.1
e6/l
43.0
154.6
0.49
60
451
(3044640) Blood type and Crossmatch panel - Blood
86
631
1.55
2.65
3.5
2.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
169
1431
1.54
2.65
3.5
3.0
u/l
40.4
41.7
0.13
157
1361
(3024561) Albumin [Mass/volume] in Serum or Plasma
103
788
1.52
2.62
7.5
4.8
g/l
36.6
36.2
0.22
98
741
(40768446) Kidney Pathology biopsy report
5
7
7.26
2.56
1.6
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
123
2.05
2.55
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
167
1420
1.51
2.49
5.9
4.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
474
1.56
2.40
2.8
2.4
mg/l
2.4
3.0
2.20
61
411
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
201
1.80
2.40
2.5
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
115
913
1.47
2.38
9.0
7.3
mmol/l
1.2
1.2
0.73
101
780
(3017704) Immunofixation for Urine
5
8
6.35
2.38
2.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
23
3.56
2.29
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
87
659
1.49
2.26
3.8
3.4
ng/l
802.4
33.7
0.48
56
406
(3000494) Fungus identified in Specimen by Culture
37
229
1.72
2.24
1.4
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
173
1500
1.48
2.20
11.1
7.1
u/l
81.6
78.6
0.40
163
1400
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
13
55
2.44
2.16
2.8
5.3
%
1.7
1.5
0.41
13
50
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
68
2.28
2.15
1.7
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
72
531
1.50
2.12
9.4
7.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
62
2.33
2.12
1.5
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
25
3.27
2.11
3.1
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
15
4.07
2.05
1.8
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
73
545
1.48
2.01
6.5
3.9
ph
7.4
7.4
—
10
96
(3032080) INR in Blood by Coagulation assay
86
664
1.45
1.99
10.0
7.1
inr
1.3
1.2
0.46
22
211
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
205
1.70
1.98
2.4
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
39
2.63
1.94
1.0
1.2
u/ml
3.4
2.7
—
5
18
(1761868) Lipid panel - Serum or Plasma
55
746
0.67
1.93
2.7
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
86
2.05
1.90
5.3
11.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
117
965
1.39
1.84
3.6
2.8
ug/l
117.3
95.1
0.24
111
897
(3013650) Neutrophils [#/volume] in Blood by Automated count
145
1240
1.39
1.84
12.3
9.6
e9/l
4.1
4.0
0.35
129
1077
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
12
4.23
1.83
1.4
1.2
u/l
214.0
79.2
—
5
6
(3013512) EKG study
65
483
1.46
1.82
3.9
3.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
51
361
1.52
1.81
1.5
1.3
iu/ml
44.0
29.3
0.25
15
119
(44813793)
5
13
3.90
1.72
1.2
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
44
305
1.53
1.72
4.2
2.8
e6/l
3.4
2.6
0.26
20
164
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
119
996
1.37
1.67
8.2
6.2
umol/l
12.5
12.8
0.04
111
938
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
179
1600
1.40
1.65
4.1
3.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
64
483
1.43
1.65
3.4
2.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
44
308
1.52
1.65
5.6
3.3
ng/l
98.3
195.0
0.50
28
213
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
310
1.51
1.60
1.8
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
62
470
1.42
1.56
1.6
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
253
0.53
1.54
1.4
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
15
3.38
1.53
8.6
1.6
mg/l
2.4
2.9
—
5
15
(3021788) Differential panel - Synovial fluid
6
21
2.90
1.51
1.3
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
46
332
1.47
1.49
4.0
2.7
e6/l
1.4
0.8
0.51
23
189
(4010399)
21
125
1.74
1.49
1.1
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
350
1.46
1.48
1.4
1.3
u/ml
17.0
9.3
0.19
18
152
(3020682) Albumin/Creatinine [Ratio] in Urine
64
494
1.39
1.45
4.9
4.0
mg/mmol
12.1
9.6
0.21
43
316
(3018095) Leukocytes [#/volume] in Urine
87
709
1.34
1.40
5.3
3.5
e6/l
57.6
93.8
0.37
64
493
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
53
2.12
1.40
1.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
17
2.98
1.36
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
178
1613
1.34
1.35
4.2
4.0
pmol/l
14.7
14.7
0.03
163
1459
(3002030) Lymphocytes/100 leukocytes in Blood
123
1060
1.31
1.33
8.7
6.3
%
30.3
29.5
0.27
117
1011
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
56
429
1.39
1.32
3.4
2.0
mg/l
1.2
1.1
0.11
45
326
(3018677) aPTT in Platelet poor plasma by Coagulation assay
36
254
1.49
1.31
3.0
2.3
s
29.4
29.6
0.07
36
246
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
28
187
1.56
1.30
2.6
2.5
u/l
45.8
29.4
0.41
23
162
(4094501)
8
34
2.40
1.30
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
215
2012
1.44
1.30
20.4
13.4
%
38.9
40.1
1.05
145
1594
(3012516) Albumin [Mass/volume] in Urine
61
476
1.37
1.29
5.7
3.1
mg/l
2509.6
61.2
0.81
40
313
(3018010) Neutrophils/100 leukocytes in Blood
121
1044
1.30
1.29
9.0
6.1
%
54.7
55.8
0.37
116
995
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
73
588
1.34
1.26
1.4
1.4
u/ml
0.6
1.7
1.69
16
152
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
49
2.08
1.23
2.7
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
86
1.79
1.22
1.7
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
37
267
1.45
1.21
3.8
2.4
g/l
2.4
2.4
0.18
31
247
(3048689) Calprotectin [Mass/mass] in Stool
44
329
1.41
1.20
3.0
2.7
ug/g
77.0
91.8
0.34
36
258
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
224
2120
1.47
1.19
20.1
12.1
mg/l
26.1
21.9
0.77
192
1597
(3044941) Cell count panel - Synovial fluid
5
20
2.53
1.15
1.2
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
39
288
1.42
1.14
1.4
1.4
titre
584.0
521.2
—
10
68
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
40
2.03
1.13
1.0
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
18
112
1.65
1.12
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
57
452
1.34
1.09
5.2
2.9
umol/l
12715.8
7464.6
0.25
49
391
(4306422)
7
32
2.22
1.09
1.3
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
32
2.22
1.09
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
202
1889
1.33
1.07
4.3
4.0
mmol/l
6.0
5.8
1.04
183
1735
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
225
0.60
1.05
1.8
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
22
2.30
1.04
1.2
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
231
2211
1.48
1.02
14.1
9.4
u/l
27.3
25.8
0.69
224
2134
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
48
1.91
1.01
1.9
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
225
1.43
1.00
3.9
4.1
%
35.1
31.4
1.55
21
147
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
23
2.20
0.98
1.2
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
23
2.20
0.98
3.2
1.6
e9/l
0.3
0.2
—
5
15
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
23
2.20
0.98
1.0
1.4
pmol/l
391.2
299.9
—
5
18
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
23
2.20
0.98
4.2
3.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
54
1.89
0.98
1.0
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
115
1012
1.25
0.97
5.2
4.7
estimate
0.0
0.0
0.00
26
206
(3019225) pH of Specimen
22
150
1.51
0.96
2.5
4.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
15
93
1.65
0.96
3.1
4.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
33
245
1.40
0.95
4.0
2.5
%
27.3
24.6
0.29
21
213
(40761511) CBC panel - Blood by Automated count
230
2205
1.44
0.94
18.4
11.2
—
—
—
0
0
(44806118)
6
27
2.25
0.94
1.0
1.5
—
—
—
0
0
(44790048)
6
27
2.25
0.94
1.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
27
2.25
0.94
1.0
1.7
—
—
—
0
0
(44790047)
6
27
2.25
0.94
1.0
1.5
—
—
—
0
0
(44790049)
6
27
2.25
0.94
1.0
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
116
1025
1.24
0.94
3.5
3.4
estimate
0.0
0.0
0.00
26
195
(40761536) Microorganisms panel - Urine sediment
26
185
1.45
0.94
3.0
3.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
110
1.58
0.93
1.4
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
28
2.17
0.92
1.0
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
28
2.17
0.92
1.0
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
23
161
1.47
0.90
4.7
9.0
%
96.2
96.1
0.03
23
155
(3015377) Calcium [Moles/volume] in Serum or Plasma
72
605
1.26
0.90
4.9
3.1
mmol/l
2.3
2.4
0.51
67
538
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
42
1.93
0.89
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
56
1.82
0.89
1.9
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
204
1927
1.29
0.88
5.1
4.7
mu/l
1.8
1.9
0.29
186
1759
(3003396) Base excess in Arterial blood by calculation
26
188
1.43
0.87
4.4
8.3
mmol/l
0.9
1.1
0.07
21
150
(3011397) Hemoglobin [Presence] in Urine by Test strip
57
467
1.28
0.87
3.6
3.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
154
1.47
0.87
5.0
12.0
mmol/l
24.5
24.7
0.09
22
154
(36660697) Celiac disease serology panel - Serum
27
197
1.41
0.86
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
80
1.66
0.86
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
146
1.48
0.85
3.4
2.8
ml/min/173m2
72.5
72.4
0.00
12
61
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
31
1.96
0.85
2.0
2.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
31
1.96
0.85
1.0
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
10
57
1.79
0.85
1.5
1.4
ug/g
198.8
317.8
—
5
28
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
65
544
1.26
0.84
1.8
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
124
1114
1.22
0.83
8.2
6.7
e9/l
0.2
0.2
0.24
110
999
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
415
1.29
0.82
2.6
2.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
123
1.50
0.80
1.4
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
24
0.00
0.79
0.0
3.9
—
84.0
—
0
24
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
95
834
1.22
0.79
2.9
2.3
nmol/l
75.8
74.4
0.17
87
751
(3022145) Colonoscopy Study observation
29
218
1.37
0.79
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
17
115
1.51
0.79
4.8
6.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
149
1.45
0.78
4.3
5.8
mmol/l
0.8
1.3
0.24
16
108
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
99
1.55
0.77
1.4
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
59
1.72
0.77
1.9
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
34
1.78
0.77
1.0
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
67
569
1.24
0.76
4.3
3.1
mmol/l
7.6
8.0
0.25
61
491
(3027801) Oxygen [Partial pressure] in Arterial blood
25
185
1.39
0.75
4.3
8.3
kpa
12.8
13.0
0.07
25
177
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
25
185
1.39
0.75
4.3
8.3
kpa
5.0
5.1
0.20
25
177
(3035350) Ketones [Presence] in Urine by Test strip
113
1014
1.21
0.75
3.4
3.3
estimate
0.0
0.0
0.00
24
204
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
24
2.10
0.75
3.2
1.5
e6/l
361.6
534.9
—
5
15
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
38
1.87
0.74
1.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
90
791
1.21
0.74
2.2
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
40
1.77
0.72
1.4
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
157
0.62
0.71
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
26
1.94
0.71
1.0
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
26
1.94
0.71
1.0
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
26
1.94
0.71
1.0
1.7
—
—
—
0
0
(3015736) pH of Urine
90
794
1.21
0.71
3.3
3.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
58
1.57
0.70
2.1
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
20
144
1.42
0.70
4.3
5.1
%
0.5
0.5
—
6
34
(3017181) Myelocytes/100 leukocytes in Blood
21
153
1.41
0.69
4.0
5.2
%
0.4
0.9
—
7
50
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
102
1.50
0.69
1.5
1.4
miu/ml
208.1
289.3
—
9
49
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
27
1.87
0.69
1.0
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
27
1.87
0.69
3.4
1.8
—
—
—
0
0
(4268621)
5
27
1.87
0.69
1.8
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
27
1.87
0.69
1.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
14
94
1.52
0.68
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
74
646
1.21
0.65
1.7
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
29
1.74
0.64
5.4
2.7
%
0.4
1.5
—
5
23
(3015171) Extractable nuclear Ab [Units/volume] in Serum
12
79
1.54
0.64
1.4
1.3
—
1.6
—
0
6
(3006315) Basophils [#/volume] in Blood
118
1077
1.18
0.62
8.0
6.2
e9/l
0.0
0.0
1.83
103
940
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
30
1.68
0.61
1.2
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
162
1519
1.18
0.61
5.7
4.0
mm/h
10.9
10.2
0.25
154
1405
(3019198) Lymphocytes [#/volume] in Blood
122
1118
1.17
0.61
7.8
6.2
e9/l
2.4
2.0
0.36
109
1001
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
51
1.59
0.61
1.1
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
26
202
1.32
0.60
3.3
3.7
%
1.6
1.8
0.33
21
188
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
64
1.59
0.59
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
63
547
1.20
0.58
1.6
1.4
g/l
1.9
2.2
1.08
41
323
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
35
1.73
0.58
1.0
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
23
177
1.33
0.57
3.2
2.9
g/l
0.2
0.2
0.02
23
167
(3012544) pH of Venous blood
27
213
1.30
0.57
4.3
5.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
185
1760
1.19
0.56
5.9
5.1
mmol/mol
40.5
39.3
0.64
168
1646
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
9
61
1.49
0.54
1.0
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
26
206
1.29
0.53
4.3
6.0
mmol/l
0.7
1.6
0.75
21
163
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
391
1.22
0.53
2.6
2.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
117
1078
1.16
0.53
8.0
6.2
e9/l
0.6
0.6
1.47
101
940
(3026008) Bacteria identified in Urine by Culture
66
581
1.18
0.53
3.4
2.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
100
0.59
0.53
1.8
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
93
1.42
0.49
1.2
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
19
146
1.33
0.48
4.2
3.6
e9/l
62.6
72.0
0.86
13
110
(3007461) Platelets [#/volume] in Blood
243
2385
1.40
0.48
28.2
18.0
e9/l
261.8
255.4
0.66
238
2324
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
117
0.67
0.47
1.4
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
25
202
1.26
0.45
1.4
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
95
1.39
0.44
1.6
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
92
0.64
0.43
2.7
3.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
243
2389
1.36
0.42
27.8
18.0
e12/l
4.5
4.5
0.23
238
2325
(46235355) HIV 1 and 2 tests - Meaningful Use set
64
573
1.16
0.42
2.1
2.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
58
1.39
0.42
8.9
2.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
260
1.22
0.42
1.7
2.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
33
1.53
0.41
2.0
2.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
33
1.53
0.41
1.2
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
243
2390
1.36
0.41
27.7
18.0
e9/l
7.1
6.7
1.07
237
2321
(4281824)
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000492) Spirometry study
23
187
1.25
0.40
1.4
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
5
34
1.48
0.40
2.6
2.4
kpa
5.1
4.8
—
5
34
(3027315) Oxygen [Partial pressure] in Blood
5
34
1.48
0.40
2.4
2.4
kpa
8.3
8.6
—
5
34
(3016879) Cocaine [Presence] in Urine
10
137
0.72
0.40
1.4
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
9.3
—
1001.8
—
0
18
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
36.0
—
0
18
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
14.3
—
1805.8
—
0
18
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
142
1.29
0.39
1.1
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
136
0.72
0.38
1.4
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
36
1.40
0.38
3.4
12.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
143
1.28
0.38
4.4
5.3
%
0.0
0.2
—
5
46
(3022621) pH of Urine by Test strip
10
135
0.73
0.37
1.6
2.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
5
37
1.36
0.37
1.2
4.2
umol/l
26.2
43.2
—
5
29
(3008898) HLA-B27 [Presence]
15
117
1.30
0.36
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
46
1.31
0.33
1.2
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
110
1.29
0.32
1.8
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
110
1.29
0.32
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
110
1.29
0.32
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
110
1.29
0.32
1.5
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
192
1863
1.12
0.31
21.9
15.0
%
13.7
13.5
0.52
192
1844
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
52
1.36
0.31
2.7
2.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
15
120
1.27
0.31
1.6
1.6
iu/l
20.1
20.5
0.02
15
97
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
111
1.28
0.30
1.5
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
10
75
1.35
0.30
1.2
1.8
—
266.7
—
0
6
(3030981) Hyaline casts [#/volume] in Urine by Automated count
8
108
0.73
0.29
2.6
2.7
e6/l
0.0
0.1
—
8
102
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
62
1.30
0.28
1.5
1.3
—
9.6
—
0
11
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
41
367
1.14
0.28
1.5
1.7
pmol/l
385.5
441.8
1.17
33
311
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
16
131
1.24
0.28
9.4
4.2
ng/l
92.4
72.6
0.62
16
120
(3019309) Folate [Moles/volume] in Red Blood Cells
35
310
1.15
0.28
2.1
1.7
nmol/l
1046.2
1202.4
0.49
30
237
(3028300) Cannabinoids [Presence] in Urine
12
150
0.79
0.28
1.3
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
64
1.26
0.27
10.4
8.1
mg/l
1.4
1.2
—
8
58
(3027008) Opiates [Presence] in Urine
12
149
0.80
0.26
1.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
149
0.80
0.26
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
226
1.17
0.26
7.3
6.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
72
1.26
0.26
1.4
2.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
73
1.24
0.25
1.1
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
148
0.80
0.25
1.3
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
133
1277
1.09
0.24
4.0
3.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
199
1.17
0.24
1.6
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
115
1.23
0.24
1.6
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
199
1946
1.10
0.23
4.2
3.9
mmol/l
1.4
1.5
0.95
181
1807
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.0
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
135
1.20
0.22
2.3
2.5
u/l
23167.6
3178.9
—
5
58
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
44.3
—
0
6
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
272.7
—
0
6
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.2
—
324.3
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
516.5
—
0
6
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
89
1.25
0.21
1.4
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
89
1.25
0.21
2.0
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
43
1.17
0.21
5.2
3.6
%
52.4
57.7
—
5
43
(3029937) Albumin [Presence] in Urine by Test strip
60
560
1.09
0.21
3.0
3.5
estimate
0.0
0.0
0.00
23
203
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
202
1980
1.10
0.21
4.7
4.3
mmol/l
2.8
2.8
0.44
182
1834
(3000991) Gas panel - Venous blood
21
183
1.16
0.21
6.9
8.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
22
249
0.87
0.20
2.5
2.7
ug/l
0.7
0.7
0.05
12
152
(3001019) Free T4 and TSH panel - Serum or Plasma
10
122
0.81
0.19
1.9
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
35
319
1.11
0.19
1.6
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
52
1.16
0.19
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
48
446
1.09
0.18
4.8
3.0
ng/l
520.7
1182.9
2.82
38
381
(40760892) CBC W Ordered Manual Differential panel - Blood
47
505
0.92
0.18
6.4
4.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
16
138
1.17
0.18
4.7
5.3
%
0.0
0.0
—
5
38
(3049717) Cytology report of Urine Cyto stain
5
68
0.73
0.17
2.2
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
206
1.13
0.16
1.6
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
199
1956
1.08
0.16
4.3
4.0
mmol/l
4.7
4.7
0.46
182
1825
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
161
0.86
0.15
5.0
10.2
mmol/l
1.1
1.4
0.67
14
152
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
39
419
0.92
0.15
1.6
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
49
460
1.08
0.15
3.3
3.4
kg/l
1.0
1.0
—
6
63
(3019832) Treponema pallidum Ab [Presence] in Serum
39
364
1.08
0.14
1.7
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
8
96
0.83
0.14
1.3
1.6
u/l
9.5
11.7
—
8
78
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
184
1870
0.94
0.13
3.8
3.5
mmol/l
1.3
1.3
0.80
167
1734
(3004588) Protein electrophoresis panel - Serum or Plasma
11
94
1.18
0.13
15.3
2.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
104
1.16
0.12
4.0
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
16
143
1.13
0.12
1.9
3.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
86
1.17
0.11
1.2
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
96
1.15
0.10
1.2
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
82
794
1.05
0.10
3.1
3.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
56
1.07
0.08
4.0
3.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
(4034850)
7
64
1.10
0.08
9.4
11.0
—
—
—
0
0
(3020891) Body temperature
7
65
1.08
0.08
2.7
4.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
68
1.03
0.08
1.6
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
73
0.82
0.07
1.5
1.5
nmol/l
31.8
39.9
—
6
73
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
7
81
0.86
0.07
2.0
4.0
%
50.6
48.4
—
7
81
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
85
0.82
0.07
1.1
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
93
0.86
0.07
2.6
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
25
236
1.07
0.06
1.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
185
1866
0.97
0.05
14.2
10.8
ml/min/173m2
88.9
87.7
0.31
147
1484
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
238
1.06
0.05
2.0
1.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
91
1.10
0.04
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
91
1.10
0.04
1.6
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
35
339
1.04
0.03
3.3
4.3
%
21.0
21.7
—
9
162
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
153
1.05
0.01
1.4
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
183
1.04
0.01
2.5
3.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
94
1.07
0.01
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
59
591
1.00
0.00
2.8
3.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
96
959
1.00
0.00
10.9
9.1
e9/l
0.0
0.0
0.75
76
774
(4035726)
17
165
1.03
0.00
1.3
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.9
—
2.4
—
0
7
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
6.7
—
0
7
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
73
0.96
0.00
1.3
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
77
0.91
0.00
1.6
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
72
0.97
0.00
1.3
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
74
0.94
0.00
1.3
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
50
1.00
0.00
1.2
1.7
e6/l
1920.6
226.8
—
5
40
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
50
1.00
0.00
1.2
1.6
e6/l
0.4
3.5
—
5
38
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
147.2
—
0
5
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
25.2
—
0.4
—
0
5
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
2.7
—
115.4
—
0
6
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
53
0.94
0.00
1.4
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
71
0.99
0.00
1.3
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
6.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
67.4
—
0
5
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
9
93
0.97
0.00
6.1
10.8
mmol/l
24.2
24.6
—
9
88
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
2.7
—
50.3
—
0
6
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
240
1.00
0.00
1.5
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
74
0.94
0.00
1.1
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
50
1.00
0.00
2.2
3.9
mmol/l
4.0
3.9
—
5
44
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_MYRINGACU and mortality.

Females

Parameter HR [95% CI] p-value
H8_MYRINGACU 1.323 [0.97, 1.81] 0.079
Birth year 0.995 [0.99, 1.0] 0.313

During the follow-up period (1.1.1998 — 31.12.2019), 58 out of 1464 females with H8_MYRINGACU died.

Males

Parameter HR [95% CI] p-value
H8_MYRINGACU 1.3 [0.92, 1.83] 0.133
Birth year 0.99 [0.98, 1.0] 0.04

During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 1363 males with H8_MYRINGACU died.

Mortality risk

Mortality risk for people of age

years, who have H8_MYRINGACU.

N-year risk Females Males
1 0.129% 0.354%
5 0.737% 1.732%
10 2.045% 4.315%
15 4.011% 8.126%
20 6.719% 13.886%

Relationships between endpoints

↥

Index endpoint: H8_MYRINGACU – Acute myringitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data